Primary hepatic carcinoma is one of the types with high incidence of cancer. It has the characteristics of hidden disease, long incubation period, rapid development and easy metastasis, and the prognosis is poor, which seriously affects the quality of life of patients.
Introduction
Primary Hepatic Carcinoma (PHC) is characterized by high morbidity and mortality. It is the fifth most common malignant tumor in the world, ranking third in the cause of cancer death.
More than 500,000 people worldwide suffer from liver cancer every year. More than half of them are in China and have shown a clear upward trend [1] . The occurrence of PHC is a multi-factor cumulative result, the cause of which is not fully understood, mainly related to the following factors: (1) Hepatitis virus: mainly Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV), especially in vivo the role of viral infection and the external environment [2] . HBV DNA and HCV RNA are the main causes of liver cancer [3] [4] , and HBV surface antibody (HBsAg) and surface e-antibody (HBeAg) in patients' serum are closely related to the occurrence of liver cancer [5] [6] . Further deterioration of the hepatitis virus will lead to liver fibrosis and eventually to liver cancer. (2) Non-viral factors: excessive drinking causes cirrhosis and is easily degraded to liver cancer [7] ; lower doses of Aflatoxin (AFT) in moldy food can cause DNA genetic information to be wrong, leading to genetic mutations that induce liver cancer;
Contamination of blue-green algae toxins in unclean drinking water can also induce liver lesions to liver cancer.
Due to the special physiological characteristics of the liver, the molecular mechanism of liver cancer is complex, including:
(1) activation of proto-oncogenes and inactivation of tumor suppressor genes [8] . Common proto-oncogenes mainly include Nras and HBVx [9] , the tumor suppressor genes mainly include p53, Rb, p21 and PTEN [10] , and the proto-oncogene and tumor suppressor gene maintain a dynamic balance in normal physiological conditions. (2) Abnormal activation of multiple molecular signaling pathways: Abnormal activation of Wnt/β-catenin signaling pathway may promote liver cancer [11] ; Hedgehog signaling pathway is not expressed in mature normal liver tissue, but in liver cancer cells Abnormally active expression [12] Traditional Chinese Medicine (TCM) usually includes a personalized diagnosis and an herbal formula using 10-20 separate herbal ingredients selected from thousands of herbal material medicines that can be used as boiled water decoctions, dried herbs Extract or as a pill [13] . The principles of diagnosis and treatment are based on the understanding of the pathology of Chinese medicine. A good TCM practice is generally considered to require a TCM syndrome model based on clinical performance, and then an individualized Chinese herbal decoction suitable for addressing ©2019 XIA Meng. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially each patient-specific TCM model [14] . As treatment will change with changes in TCM patterns and clinical performance. TCM is a dynamic, highly responsive medical system that is increasingly emphasized in systems biology strategies with the use of multiple methods for optimal diagnosis and individualized treatment to account for variable responses to modern drugs.
In the TCM theory, the incidence of PHC is mostly caused by emotions, diet or toxins, resulting in visceral qi deficiency, qi ji dysfunction, and wet, phlegm, and phlegm. According to the TCM treatment of PHC, the doctors of previous generations classified the liver cancer into Chinese medicine models (phenotypes) with different characteristics according to their clinical manifestations.
Some scholars [15] 
Diagnosis of PHC
The incidence of PHC is high, which seriously threatens the life In recent years, AFP-L3 has been increasingly recognized as the diagnostic marker of sensitivity over AFP [16] . Abnormal 2019, V(1): [1] [2] [3] [4] [5] [6] [7] [8] [9] prothrombin (DCP) is carboxylated in liver microsomes catalyzed by VitK-dependent glutamyl and γ-carboxylase. In recent years, it has been found that the expression of DCP is closely related to the size and number of hepatocellular carcinoma lesions and whether there is intrahepatic or extrahepatic metastasis.
Golgi transmembrane Glycoprotein 73 (GP73) levels are significantly elevated in the serum of patients with liver cancer, which is of great significance for the diagnosis of liver cancer [17] . DKK1 is a secreted inhibitory factor, which is closely related Glypican 3 (GPC3) is a heparan sulfate glycan protein that plays an important role in the proliferation and metastasis of liver cancer cells [18] . Transforming growth factor β1 (TGF-β1) is an important regulator that strongly inhibits the proliferation of hepatocytes.
Studies have shown that TGF-β1 can promote the growth of tumor cells by inhibiting the growth of paraneoplastic cells, and its serum level is negatively correlated with the occurrence of hepatocellular carcinoma. Carcinoembryonic Antigen (CEA) is an acid glycoprotein study [19] , CEA is an independent predictor of hepatocellular carcinoma through epithelial-mesenchymal transition and tumor angiogenesis recurrence. Cancer antigen 125 (CA125) is derived from glycol proteins in the body cavity of embryonic development. When the body becomes cancerous, the level of CA125 is increased, which plays a crucial role in the early detection of tumors. CA199 is a non-specific tumor-associated oligosaccharide antigen, which is extremely low in healthy people.
In many epithelial malignancies differentiated from endoderm cells, serum CA199 levels can be At present, the main joint detection methods include: joint detection of AFP, AFP-L3, DCP [20] ; joint detection of AFP, DCP, GP73 [21] ; joint detection of AFP, DCP, DKK1 [22] ; AFP, AFU, Combined detection of ALP [23] ; AFP, GPC3, TGF-β1 combined detection [24] ; AFP, CEA, CA125, CA199 combined detection [25] ; AFP, CEA, Fer, CA153, CA125, CA199, TSGF combination Detection [26] . These combined tests have greatly improved the diagnostic rate of primary liver cancer.
Treatment of PHC in Modern Medicine
Modern treatment of PHC usually includes (1) surgery, minimally invasive interventional therapy and liver transplantation; (2) radiotherapy and chemotherapy; (3) biopharmaceutical treatment; (4) cardiac adjuvant therapy.
Surgery and minimally invasive interventional techniques for the treatment of PHC
Surgical resection of PHC is currently the most widely used radical treatment. Early PHC surgery has a good prognosis and high survival rate after surgery. In the middle and late stage PHC, especially large liver cancer or multiple cancer, the rate of radical resection is low and the prognosis is poor [27] .
According to the statistical analysis [28] , the survival rate within 5 years after PHC resection is less than 40%, and the recurrence and metastasis rate is as high as 70%.
Interventional therapy is another important method after surgical treatment, mainly for transcatheter arterial chemoembolization (TACE), which has less effect on postoperative depression than surgery. Shi YZ [29] compared the anxiety and depression of patients with PHC after surgical resection and TACE combined with microwave ablation (PMCT). The incidence of anxiety and depressive symptoms in the PMCT group was significantly lower than that in the surgical resection group. However, TACE is a topical treatment, making it less desirable for long-term clinical 2019 
Biopharmaceutical treatment of PHC
Biopharmaceutical treatment PHC has also been widely carried out, including: molecular targeted therapy, gene therapy, immunotherapy and many other aspects. Biotherapy is to enhance the body's immunity by regulating the physiological functions of the body, inhibiting the growth of tumor cells, improving the survival rate of patients and reducing the recurrence rate of tumors. However, most bio therapeutic techniques are still immature and still need to be developed [35] .
Most studies [36] [37] found that postoperative drug intervention has a good effect on PHC. 
Chinese medicine treatment PHC
The causes of PHC in traditional Chinese medicine are mostly caused by emotions, diet or toxins, resulting in viscera deficiency of vital energy, the movement imbalance of gas, and wet, blood stasis, and sputum. Liver qi stagnation is the root cause, leading to the occurrence and development of liver cancer. Curcumin [62] , Dihydroartemisinin [63] , and Diterpenoids in JD. [64] .
Inducing apoptosis of liver cancer cells: Apoptosis is
an intrinsic programmed suicide mechanism in which cells are controlled to disintegrate into apoptotic bodies, which are then recognized and phagocytosed by phagocytic cells, which is an important mechanism for maintaining a constant number of organs and a stable inner loop. It plays an important role in the process of tumor development and elimination. Studies have found that Chinese herbal medicines that can induce apoptosis of liver cancer cells include: Scutellaria extract β-elemene [65] , Tanshinone IIA [66] , Piperine [67] , and Icariin [68] .
Anti-hepatocarcinoma invasion and metastasis:
Primary tumor invasion and metastasis are the basic biological characteristics of malignant tumors, and are the lethal factors of most tumor patients in clinical practice. Liver cancer is easy to metastasize and easy to relapse, and the therapeutic effect is difficult to fundamentally improve. In recent years, Chinese medicine has made great progress in this research. Studies have found that Chinese herbal medicines with anti-hepatocarcinoma invasion and metastasis include: Total saponins of paeonia [69] and Ginsenoside Rg3 [70] . 
Affecting telomerase activity:

